GNG7 silencing promotes the proliferation and differentiation of placental cytotrophoblasts in preeclampsia rats through activation of the mTOR signaling pathway

Lai,Wei‑Si; Ding,Yi‑Ling

doi:10.3892/ijmm.2019.4129

GNG7 silencing promotes the proliferation and differentiation of placental cytotrophoblasts in preeclampsia rats through activation of the mTOR signaling pathway

Authors:
- Wei‑Si Lai
- Yi‑Ling Ding
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China
Published online on: March 12, 2019 https://doi.org/10.3892/ijmm.2019.4129
Pages: 1939-1950
Copyright: © Lai et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Preeclampsia (PE) is a pathological condition that manifests during pregnancy as the occurrence of an abnormal urine protein level and increased blood pressure due to inadequate cytotrophoblast invasion. To elucidate the mechanism underlying PE, the present study primarily focused on the regulatory effects and mechanism of the G protein γ 7 (GNG7) on placental cytotrophoblasts in a rat PE model. Initially, the PE model was established with 45 specific pathogen‑free Sprague‑Dawley rats (30 females and 15 males). The expression patterns of GNG7, 4E‑binding protein 1 (4E‑BP1), phosphoprotein 70 ribosomal protein S6 kinase (p70S6K) and mammalian target of rapamycin (mTOR) were examined in the PE rats. Placental cytotrophoblasts isolated from normal and PE rats were treated with a small interfering RNA against GNG7, mTOR signaling pathway activator (HIV‑1 Tat) or inhibitor (rapamycin). Following treatment, cell proliferation, differentiation and apoptosis were evaluated, and mTOR signaling pathway‑related factors (4E‑BP1, p70S6K and mTOR), cell proliferation‑related factors (vascular endothelial growth factor and transforming growth factor‑β1), differentiation‑related factors [activator protein‑2 (AP‑2)α and AP‑2γ], and apoptosis‑related factors [B‑cell lymphoma 2 (Bcl‑2) and Bcl‑2‑associated X protein] were determined. Finally, soluble fms‑like tyrosine kinase 1 (sFlt‑1) and soluble endoglin (sEng) levels were measured via enzyme‑linked immunosorbent assay. Initially, the mTOR signaling pathway was inactivated in the placental tissues and cytotrophoblasts in the PE rats. Silencing GNG7 reduced the levels of sFlt‑1 and sEng and activated the mTOR signaling pathway. Silencing of GNG7 or activation of the mTOR signaling pathway enhanced cell proliferation and differentiation, but inhibited the apoptosis of placental cytotrophoblasts in the PE rats. Taken together, the results showed that GNG7 silencing repressed apoptosis and enhanced the proliferation and differentiation of placental cytotrophoblasts in PE rats through activation of the mTOR signaling pathway.

View Figures

View References

1	Ghulmiyyah L and Sibai B: Maternal mortality from preeclampsia/eclampsia. Semin Perinatol. 36:56–59. 2012. View Article : Google Scholar : PubMed/NCBI
2	Phipps E, Prasanna D, Brima W and Jim B: Preeclampsia: Updates in pathogenesis, definitions, and guidelines. Clin J Am Soc Nephrol. 11:1102–1113. 2016. View Article : Google Scholar : PubMed/NCBI
3	Staff AC, Benton SJ, von Dadelszen P, Roberts JM, Taylor RN, Powers RW, Charnock-Jones DC and Redman CW: Redefining preeclampsia using placenta-derived biomarkers. Hypertension. 61:932–942. 2013. View Article : Google Scholar : PubMed/NCBI
4	Burwick RM and Feinberg BB: Eculizumab for the treatment of preeclampsia/HELLP syndrome. Placenta. 34:201–203. 2013. View Article : Google Scholar
5	Hansson SR, Gram M and Akerstrom B: Fetal hemoglobin in preeclampsia: A new causative factor, a tool for prediction/diagnosis and a potential target for therapy. Curr Opin Obstet Gynecol. 25:448–455. 2013. View Article : Google Scholar : PubMed/NCBI
6	Liu J, Ji X, Li Z, Yang X, Wang W and Zhang X: G protein gamma subunit 7 induces autophagy and inhibits cell division. Oncotarget. 7:24832–24847. 2016.PubMed/NCBI
7	Hartmann S, Szaumkessel M, Salaverria I, Simon R, Sauter G, Kiwerska K, Gawecki W, Bodnar M, Marszalek A, Richter J, et al: Loss of protein expression and recurrent DNA hypermethylation of the GNG7 gene in squamous cell carcinoma of the head and neck. J Appl Genet. 53:167–174. 2012. View Article : Google Scholar :
8	Kvehaugen AS, Melien O, Holmen OL, Laivuori H, Oian P, Andersgaard AB, Dechend R and Staff AC: Single nucleotide polymorphisms in G protein signaling pathway genes in preeclampsia. Hypertension. 61:655–661. 2013. View Article : Google Scholar : PubMed/NCBI
9	Populo H, Lopes JM and Soares P: The mTOR signalling pathway in human cancer. Int J Mol Sci. 13:1886–1918. 2012. View Article : Google Scholar : PubMed/NCBI
10	Gomez-Pinillos A and Ferrari AC: mTOR signaling pathway and mTOR inhibitors in cancer therapy. Hematol Oncol Clin North Am. 26:483–505. 2012. View Article : Google Scholar : PubMed/NCBI
11	Zeng X, Huang Z, Mao X, Wang J, Wu G and Qiao S: N-carbamylglutamate enhances pregnancy outcome in rats through activation of the PI3K/PKB/mTOR signaling pathway. PLoS One. 7:e411922012. View Article : Google Scholar : PubMed/NCBI
12	Wu D, Hong H, Huang X, Huang L, He Z, Fang Q and Luo Y: CXCR2 is decreased in preeclamptic placentas and promotes human trophoblast invasion through the Akt signaling pathway. Placenta. 43:17–25. 2016. View Article : Google Scholar : PubMed/NCBI
13	Amaral LM, Cornelius DC, Harmon A, Moseley J, Martin JN Jr and LaMarca B: 17-hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model. Hypertension. 65:225–231. 2015. View Article : Google Scholar
14	Serman L, Vlahovic M, Sijan M, Bulic-Jakus F, Serman A, Sincic N, Matijevic R, Juric-Lekic G and Katusic A: The impact of 5-azacytidine on placental weight, glycoprotein pattern and proliferating cell nuclear antigen expression in rat placenta. Placenta. 28:803–811. 2007. View Article : Google Scholar : PubMed/NCBI
15	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
16	Bergmann A, Ahmad S, Cudmore M, Gruber AD, Wittschen P, Lindenmaier W, Christofori G, Gross V, Gonzalves ACh Grone HJ, et al: Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model. J Cell Mol Med. 14:1857–1867. 2010. View Article : Google Scholar
17	Grotegut CA: Prevention of preeclampsia. J Clin Invest. 126:4396–4398. 2016. View Article : Google Scholar : PubMed/NCBI
18	Velicky P, Windsperger K, Petroczi K, Pils S, Reiter B, Weiss T, Vondra S, Ristl R, Dekan S, Fiala C, et al: Pregnancy-associated diamine oxidase originates from extravillous trophoblasts and is decreased in early-onset preeclampsia. Sci Rep. 8:63422018. View Article : Google Scholar : PubMed/NCBI
19	Wang M, Gong B, Li Y and Wang Y: Human G-protein gamma 7 in extrahepatic cholangiocarcinoma and its clinicopathological significance. Hematol Oncol Stem Cell Ther. 3:66–70. 2010. View Article : Google Scholar : PubMed/NCBI
20	Giguere V: Canonical signaling and nuclear activity of mTOR-a teamwork effort to regulate metabolism and cell growth. FEBS J. 285:1572–1588. 2018. View Article : Google Scholar : PubMed/NCBI
21	Aiko Y, Askew DJ, Aramaki S, Myoga M, Tomonaga C, Hachisuga T, Suga R, Kawamoto T, Tsuji M and Shibata E: Differential levels of amino acid transporters System L and ASCT2, and the mTOR protein in placenta of preeclampsia and IUGR. BMC Pregnancy Childbirth. 14:1812014. View Article : Google Scholar : PubMed/NCBI
22	Zhou K, Fan YD, Wu PF, Duysenbi S, Feng ZH, Du GJ and Zhang TR: MicroRNA-145 inhibits the activation of the mTOR signaling pathway to suppress the proliferation and invasion of invasive pituitary adenoma cells by targeting AKT3 in vivo and in vitro. Onco Targets Ther. 10:1625–1635. 2017. View Article : Google Scholar : PubMed/NCBI
23	Wang G, Liu M, Wang H, Yu S, Jiang Z, Sun J, Han K, Shen J, Zhu M, Lin Z, et al: Centrosomal protein of 55 regulates glucose metabolism, proliferation and apoptosis of glioma cells via the Akt/mTOR signaling pathway. J Cancer. 7:1431–1440. 2016. View Article : Google Scholar : PubMed/NCBI
24	Orso F, Penna E, Cimino D, Astanina E, Maione F, Valdembri D, Giraudo E, Serini G, Sismondi P, De Bortoli M and Taverna D: AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs. FASEB J. 22:2702–2714. 2008. View Article : Google Scholar : PubMed/NCBI
25	Biadasiewicz K, Sonderegger S, Haslinger P, Haider S, Saleh L, Fiala C, Pollheimer J and Knofler M: Transcription factor AP-2α promotes EGF-dependent invasion of human trophoblast. Endocrinology. 152:1458–1469. 2011. View Article : Google Scholar : PubMed/NCBI
26	Zhang L, Jia L, Cui S, Shi Y, Chang A, Wang P and Zhang Z: AP-2alpha-dependent regulation of Bcl-2/Bax expression affects apoptosis in the trophoblast. J Mol Histol. 43:681–689. 2012. View Article : Google Scholar : PubMed/NCBI
27	Wang A, Liu Q, Zhang J and Zheng R: Berberine alleviates preeclampsia possibly by regulating the expression of interleukin-2/interleukin-10 and Bcl-2/Bax. Int J Clin Exp Med. 8:16301–16307. 2015.PubMed/NCBI
28	Schneider HA, Gembruch U, Fimmers R, Schmitz J and Muller AM: Expression of AP-2γ in placentas of patients with preeclampsia and of smokers. Arch Gynecol Obstet. 291:1015–1021. 2015. View Article : Google Scholar
29	Hu LY, Sun ZG, Wen YM, Cheng GZ, Wang SL, Zhao HB and Zhang XR: ATP-mediated protein kinase B Akt/mammalian target of rapamycin mTOR/p70 ribosomal S6 protein p70S6 kinase signaling pathway activation promotes improvement of locomotor function after spinal cord injury in rats. Neuroscience. 169:1046–1062. 2010. View Article : Google Scholar : PubMed/NCBI
30	Wahl EA, Schenck TL, Machens HG and Balmayor ER: VEGF released by deferoxamine preconditioned mesenchymal stem cells seeded on collagen-GAG substrates enhances neovascularization. Sci Rep. 6:368792016. View Article : Google Scholar : PubMed/NCBI
31	Escudero C, Bertoglia P, Hernadez M, Celis C, Gonzalez M, Aguayo C and Acurio J: Impaired A2A adenosine receptor/nitric oxide/VEGF signaling pathway in fetal endothelium during late- and early-onset preeclampsia. Purinergic Signal. 9:215–226. 2013. View Article : Google Scholar :
32	Khanabdali R, Shakouri-Motlagh A, Wilkinson S, Murthi P, Georgiou HM, Brennecke SP and Kalionis B: Low-dose aspirin treatment enhances the adhesion of preeclamptic decidual mesenchymal stem/stromal cells and reduces their production of pro-inflammatory cytokines. J Mol Med (Berl). 96:1215–1225. 2018. View Article : Google Scholar
33	Kintiraki E, Papakatsika S, Kotronis G, Goulis DG and Kotsis V: Pregnancy-induced hypertension. Hormones (Athens). 14:211–223. 2015. View Article : Google Scholar
34	Lu F, Longo M, Tamayo E, Maner W, Al-Hendy A, Anderson GD, Hankins GD and Saade GR: The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. Am J Obstet Gynecol. 196. pp. 396 e391–397; discussion 396 e397. 2007, View Article : Google Scholar
35	Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, et al: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 111:649–658. 2003. View Article : Google Scholar : PubMed/NCBI
36	Ohkuchi A, Hirashima C, Suzuki H, Takahashi K, Yoshida M, Matsubara S and Suzuki M: Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia. Hypertens Res. 33:422–427. 2010. View Article : Google Scholar : PubMed/NCBI
37	Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, et al: Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 12:642–649. 2006. View Article : Google Scholar : PubMed/NCBI